Furthermore, higher efficacy (Table 4) of angiotensin II-targeted agents when applied to carriers of the minor allele of rs1053239 or rs2479 highlighted the contribution of RAAS activation upon CIDEC variation in the pathophysiology of hypertension. Here, AGT is linked to hypertensive disorder.